We are live on ! Find out more
MESO

Mesoblast

17 hedge funds and large institutions have $10.7M invested in Mesoblast in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

13% more funds holding

Funds holding: 1517 (+2)

4% more capital invested

Capital invested by funds: $10.3M → $10.7M (+$405K)

Holders
17
Holders Change
+2
Holders Change %
+13.33%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
3
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

MESO Hedge Fund Activity: Q3 2016 in Review

17 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q3 2016, worth a combined $10.7M — up 4% from $10.3M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new MESO positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Penbrook Management, opening a new position worth an estimated $146K. The largest seller was Credit Suisse, exiting entirely with an estimated $535K sold.

  • 17 institutional investors held Mesoblast (MESO) as of Q3 2016, up from 15 in Q2 2016.
  • Funds reported $10.7M of Mesoblast stock for Q3 2016, up 4% quarter-over-quarter.
  • 5 funds opened new Mesoblast positions in Q3 2016 and 3 closed out, a net change of +2 holders.
  • The largest Mesoblast buyer in Q3 2016 was Penbrook Management, an estimated $146K added.
  • The largest Mesoblast seller in Q3 2016 was Credit Suisse, an estimated $535K sold.

Based on aggregated 13F filings for Q3 2016.